Indivior Pharmaceuticals — Investor Day (December 2022)

6 slides from Indivior Pharmaceuticals's investor day presentation, Dec 7, 2022

Slide 1: Indivior
ae INDIVIOR’ | °°"
Slide 2: Capital Markets Day, December 7, 2022
Capital Markets Day December 7, 2022
Slide 3: Biographies
CAPITAL MARKETS DAY | POSITIONED FOR CONTINUED VALUE CREATION Biographies Mark was appointed Chief Executive Officer in June 2020. Mark was appointed to the Board and as Chief Financial Operations in February 2017. In July 2019, Mark took on additional responsibilities and was appointed Chief Financ
Slide 4: Biographies
CAPITAL MARKETS DAY | POSITIONED FOR CONTINUED VALUE CREATION Biographies Terry is responsible for developing a deep understanding of patients’ needs and translating them into an actionable strategy to ensure that all patients have access to evidence-based treatment. Terry brings over three decades
Slide 5: Biographies
CAPITAL MARKETS DAY | POSITIONED FOR CONTINUED VALUE CREATION Biographies Vishal Kalia is an internationally recognized senior executive with 20+ years global experience, delivered award-winning campaigns, launched multi-million-dollar brands, worked across the globe. He has been in Indivior since 2
Slide 6: Biographies
CAPITAL MARKETS DAY | POSITIONED FOR CONTINUED VALUE CREATION Biographies Ryan was appointed Chief Financial Officer and Executive Director in November 2020, having served as Interim Financial Officer since June 2020. Ryan has been in a financial leadership capacity since joining Indivior in 2012 an